Knight Therapeutics Inc. said it acquired an additional 754,716 shares of Crescita Therapeutics Inc. for C$400,000.
The Canadian specialty pharmaceutical company participated in Crescita's rights offering to raise C$3.7 million via the sale of 7,001,603 shares.
Knight Therapeutics now owns 2,834,689 shares of Crescita, representing 13.5% of the company. It previously owned 2,079,973 shares representing 14.9% of Crescita; its ownership has diluted as a result of the latest rights offering.
Knight's ownership in Crescita is for investment purposes.
